Hamid Akbarali

Title: Innovations by Hamid Akbarali in Opioid Prodrugs

Introduction

Hamid Akbarali is an accomplished inventor based in Richmond, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic opioid prodrugs. His work aims to improve pain management while minimizing the adverse effects commonly associated with opioid use.

Latest Patents

Hamid Akbarali holds a patent for "Nanoparticle conjugated synthetic opioid prodrugs and methods of their uses." This innovative patent describes nanoparticle conjugated synthetic opioid prodrugs that specifically target the peripheral mu opioid receptor (MOR). The prodrugs are designed to exhibit long-lived bioavailability, ensuring that they do not compromise the analgesic effects of opioids administered for pain relief. In some cases, these prodrugs can even be utilized for pain relief themselves. Importantly, they do not induce opioid withdrawal symptoms when their use is discontinued. Certain prodrugs developed by Akbarali are particularly beneficial for preventing and treating unwanted opioid-induced side effects, such as opioid-induced constipation (OIC).

Career Highlights

Hamid Akbarali is affiliated with Virginia Commonwealth University, where he continues to advance his research and innovations in the field of opioid medications. His work is pivotal in addressing the ongoing opioid crisis by providing safer alternatives for pain management.

Collaborations

Some of his notable coworkers include Yan Zhang and Hu Yang, who contribute to the collaborative efforts in research and development at Virginia Commonwealth University.

Conclusion

Hamid Akbarali's innovative work in developing nanoparticle conjugated synthetic opioid prodrugs represents a significant advancement in pain management. His contributions aim to enhance patient care while mitigating the risks associated with traditional opioid therapies.